Bollard Group LLC Abb Vie Inc. Transaction History

Bollard Group LLC

$3.31 Billion
Q1 2024

A detailed history of Bollard Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bollard Group LLC holds 3,623 shares of ABBV stock, worth $593,592. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,623

Previous 3,866 6.29%

Holding current value

$593,592

Previous $599,000 10.18%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $38,836 - $44,250	-243 Reduced 6.29%	3,623 $660,000
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $99,347 - $111,888	-722 Reduced 15.74%	3,866 $599,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $3,339 - $3,866	25 Added 0.55%	4,588 $684,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $20,009 - $24,899	151 Added 3.42%	4,563 $615,000
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $3,326 - $3,830	23 Added 0.52%	4,412 $703,000

Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $3,181 - $3,815	23 Added 0.53%	4,389 $709,000
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $3,221 - $3,694	24 Added 0.55%	4,366 $586,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $3,027 - $3,849	22 Added 0.51%	4,342 $665,000
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $3,167 - $3,930	24 Added 0.56%	4,320 $700,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $2,793 - $3,534	26 Added 0.61%	4,296 $582,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $2,766 - $3,140	26 Added 0.61%	4,270 $461,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $2,630 - $2,930	25 Added 0.59%	4,244 $478,000
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $2,864 - $3,153	28 Added 0.67%	4,219 $457,000
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $2,173 - $2,934	27 Added 0.65%	4,191 $449,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $2,405 - $2,823	28 Added 0.68%	4,164 $365,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $2,054 - $2,749	28 Added 0.68%	4,136 $406,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $1,677 - $2,542	26 Added 0.64%	4,108 $313,000
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $1,947 - $2,436	27 Added 0.67%	4,082 $361,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $2,141 - $2,574	34 Added 0.85%	4,055 $307,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1,839 - $2,351	28 Added 0.7%	4,021 $292,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $2,082 - $2,451	27 Added 0.68%	3,993 $322,000
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $9,419 - $11,617	121 Added 3.15%	3,966 $366,000
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $1,778 - $1,976	20 Added 0.52%	3,845 $364,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $1,616 - $1,912	18 Added 0.47%	3,825 $354,000
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $1,196 - $1,601	13 Added 0.34%	3,807 $360,000
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $1,164 - $1,276	13 Added 0.34%	3,794 $367,000
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $264,102 - $337,340	3,781	3,781 $336,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Abb Vie Inc. Transaction History